Cerebral is a telehealth company that can diagnose mental illness in 30 minutes. Some nurses say they felt pressure to prescribe meads, including stimulants. Company says it's not their job to tell them what to prescribe. They're being investigated for possible violations of the controlled substances act.
The mental health startup Cerebral benefited from pandemic-era changes to federal telehealth laws. But its easy-to-get prescriptions for tightly regulated stimulants — heavily promoted on social media — have sparked a Department of Justice investigation.
This episode was produced by Tori Dominguez, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Paul Mounsey, and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices